Cathepsin E (CTSE) Peptid
CTSE
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN938721
Kurzübersicht für Cathepsin E (CTSE) Peptid (ABIN938721)
Target
Cathepsin E (CTSE)
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- GILGLGYPSL AVGGVTPVFD NMMAQNLVDL PMFSVYMSSN PEGGAGSELI
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CTSE antibody,
Alternative Names: CTSE control peptide, CTSE antibody Blocking Peptide, Anti-CTSE Blocking Peptide, cathepsin E Blocking Peptide, CATE Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- Cathepsin E (CTSE)
-
Hintergrund
- The protein encoded by this gene is a gastric aspartyl protease that functions as a disulfide-linked homodimer. This protease, which is a member of the peptidase C1 family, has a specificity similar to that of pepsin A and cathepsin D. It is an intracellular proteinase that does not appear to be involved in the digestion of dietary protein and is found in highest concentration in the surface of epithelial mucus-producing cells of the stomach. It is the first aspartic proteinase expressed in the fetal stomach and is found in more than half of gastric cancers. It appears, therefore, to be an oncofetal antigen. Transcript variants utilizing alternative polyadenylation signals and two transcript variants encoding different isoforms exist for this gene.
-
Molekulargewicht
- 40 kDa
Target
-
Sie sind hier:
